1-3 of 3
Delphine Réa
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

High Efficacy and Particular Safety Profile of Imatinib Mesylate (Glivec®) in Elderly Patients with CML in Chronic Phase: Results of the AFR04 Prospective Study.

Philippe Rousselot, Franck Nicolini, François Xavier Mahon, Delphine Réa, Jérome Jaubert, Christian Berthou, Josy Reiffers, Joelle Guilhot, François Guilhot
Journal: Blood
Blood (2007) 110 (11): 1039.
https://doi.org/10.1182/blood.V110.11.1039.1039
Published: 2007
Journal Articles

Imatinib Mesylate Discontinuation in Patients with Chronic Myelogenous Leukemia in Complete Molecular Remission: An Update Follow Up.

Francois-Xavier Mahon, MD, PhD, Francoise Huguet, MD, Gabriel Etienne, MD, Delphine Réa, MD,PhD, Jean-Michel Cayuela, PharmD,PhD, Gerald Marit, MD, Martine Gardembas, MD, Josy Reiffers, MD, Rousselot Philippe, MD,PhD
Journal: Blood
Blood (2006) 108 (11): 2154.
https://doi.org/10.1182/blood.V108.11.2154.2154
Published: 2006
Journal Articles

Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome–positive acute lymphoblastic leukemia: results of the GRAAPH-2003 study

Clinical Trials & Observations
Adrienne de Labarthe, Philippe Rousselot, Françoise Huguet-Rigal, Eric Delabesse, Francis Witz, Sébastien Maury, Delphine Réa, Jean-Michel Cayuela, Marie-Christine Vekemans, Oumedaly Reman, Agnès Buzyn, Arnaud Pigneux, Martine Escoffre, Yves Chalandon, Elizabeth MacIntyre, Véronique Lhéritier, Jean-Paul Vernant, Xavier Thomas, Norbert Ifrah, Hervé Dombret, for the Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL)
Journal: Blood
Blood (2006) 109 (4): 1408–1413.
https://doi.org/10.1182/blood-2006-03-011908
Published: 2006
Includes: Supplemental data